The effect of clodronate on a mevalonate kinase deficiency cellular model

Inflammation Research

Volumn 61, Issue 12, 2012, Pages 1363-1367

  Zanin, Valenti ^a   Marcuzzi, Annalis ^a   Piscianz, Elisa ^a   Vuch, Josef ^a   Bianco, Anna Monica ^a   Monasta, Lorenzo ^a   Decorti, Giuliana ^b   Crovella, Sergio ^b  

^a INSTITUTE FOR MATERNAL AND CHILD HEALTH IRCCS BURLO GAROFOLO   (Italy)

^b UNIVERSITY OF TRIESTE   (Italy)

Author keywords

Apoptosis; Clodronate; Mevalonate kinase deficiency; Nitric oxide

Indexed keywords

CLODRONIC ACID; NITRIC OXIDE;

ADULT; ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; APOPTOSIS; ARTICLE; BIOLOGICAL ACTIVITY; CASE REPORT; CHILD; DRUG EFFICACY; FEMALE; HUMAN; HUMAN CELL; MALE; MEVALONATE KINASE DEFICIENCY; MONOCYTE; MOUSE; NONHUMAN; PRESCHOOL CHILD; SCHOOL CHILD; TREATMENT RESPONSE;

ADOLESCENT; ADULT; ALENDRONATE; ANIMALS; ANTI-INFLAMMATORY AGENTS; APOPTOSIS; CELL LINE; CELLS, CULTURED; CHILD; CLODRONIC ACID; FEMALE; HUMANS; INFLAMMATION; LIPOPOLYSACCHARIDES; MALE; MEVALONATE KINASE DEFICIENCY; MICE; MODELS, BIOLOGICAL; MONOCYTES; NITRIC OXIDE; YOUNG ADULT;

EID: 84872194041     PISSN: 10233830     EISSN: 1420908X     Source Type: Journal    
DOI: 10.1007/s00011-012-0537-4     Document Type: Article

References (15)

1. Kuijk LM, Beekman JM, Koster J, et al. HMG-CoA reductase inhibition induces IL-1beta release through Rac1/PI3 K/PKBdependent caspase-1 activation. Blood. 2008;112:3563-73 .
2. Mandey SH, Kuijk LM, Frenkel J, et al. A role for geranylgeranylation in interleukin-1beta secretion. Arthritis Rheum. 2006;54:3690-5 .
3. Marcuzzi A, Pontillo A, De Leo L, et al. Natural isoprenoids are able to reduce inflammation in a mouse model of mevalonate kinase deficiency. Pediatr Res. 2008;64:177-82 .
4. Bodar EJ, van der Hilst JC, Drenth JP, et al. Effect of etanercept and anakinra on inflammatory attacks in the hyper-IgD syndrome: introducing a vaccination provocation model. Neth J Med. 2005; 63:260-4 .
5. Marcuzzi A, Piscianz E, Girardelli M, et al. Defect in mevalonate pathway induces pyroptosis in Raw 264.7 murine monocytes. Apoptosis. 2011;16:882-8 .
6. Marcuzzi A, Tommasini A, Crovella S, et al. Natural isoprenoids inhibit LPS induced-production of cytokines and nitric oxide in aminobisphosphonate- treated monocytes. Int Immunopharmacol. 2010;10:639-42 .
7. Cailliez M, Garaix F, Rousset-Rouviere C, et al. Anakinra is safe and effective in controlling hyperimmunoglobulinaemia D syndrome- associated febrile crisis. J Inherit Metab Dis. 2006;29:763 .
8. van der Hilst JC, Bodar EJ, Barron KS, et al. Long-term followup, clinical features and quality of life in a series of 103 patients with hyperimmunoglobulinemia D syndrome. Medicine. 2008; 87:301-10 .
9. Shikama Y, Nagai Y, Okada S, et al. Pro-IL-1beta accumulation in macrophages by alendronate and its prevention by clodronate. Toxicol Lett. 2010;199:123-8 .
10. De Leo L, Marcuzzi A, Decorti G, et al. Targeting farnesyltransferase as a novel therapeutic strategy for mevalonate kinase deficiency: in vitro and in vivo approaches. Pharmacol Res. 2010;61:506-10 .
11. Makkonen N, Salminen A, Rogers MJ, et al. Contrasting effects of alendronate and clodronate on RAW 264 macrophages: the role of a bisphosphonate metabolite. Eur J Pharm Sci. 1999;8:109-18 .
12. Frith JC, Rogers MJ. Antagonist effects of different classes of bisphosphonates in osteoclasts and macrophages in vitro. J Bone Miner Res. 2003;18:204-12 .
13. Moreau MF, Guillet C, Massin P, et al. Comparative effects of five bisphosphonates on apoptosis of macrophage cells in vitro. Biochem Pharmacol. 2007;73:718-23 .
14. Makkonen N, Hirvonen MR, Teravainen T, et al. Different effects of three bisphosphonates on nitric oxide production by Raw 264 macrophages-like cells in vitro. J Pharmacol Exp Ther. 1996;277:1097-102 .
15. Russell RG. Bisphosphonates: the first 40 years. Bone. 2011;49:2-19 .